Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53- deficient mice

Cancer Research

Volumn 57, Issue 21, 1997, Pages 4667-4672

  Dunn, Sandra E ^a   Kari, Frank W ^a   French, John ^a   Leininger, Joel R ^a   Travlos, Greg ^a   Wilson, Ralph ^a   Barrett, J Carl ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; PROTEIN P53;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER PREVENTION; CELL PROLIFERATION; DIET RESTRICTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH;

ANILINE COMPOUNDS; ANIMALS; APOPTOSIS; CARCINOGENS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; DISEASE PROGRESSION; HYPERPLASIA; INCIDENCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, TRANSGENIC; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0030727705     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Doll, R., and Peto, R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst., 66: 1191-1308, 1981.
2. Sarkar, N. H., and Reddy, B. S. Both dietary calorie and fat affect the growth of transplanted mammary tumors in RIII/Sa mice: the effect of calorie is more profound than the effect of fat. Int. J. Oncol., 6: 1149-1157, 1995.
3. Weindruch, R., and Walford, R. L. The Retardation of Aging and Disease by Dietary Restriction. Springfield, IL: C. Thomas, 1988.
4. Silverstone, H., and Tannenbaum, A. Proportion of dietary protein and the formation of spontaneous hepatomas in the mouse. Cancer Res., 11: 442, 1951.
5. Hursting, S. D., Perkins, S. N., and Phang, J. M. Caloric restriction delays spontaneous tumorigenesis in p53 knockout transgenic mice. Proc. Natl. Acad. Sci. USA, 91: 7036-7040, 1994.
6. Parr, T. Insulin exposure controls the rate of mammalian aging. Mech. Ageing Dev., 88: 75-82, 1996.
7. Hursting, S. D., Switzer, B. R., French, J. E., and Kari, F. W. The growth hormone: insulin-like growth factor I axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats. Cancer Res., 53: 2750-2757, 1993.
8. Baserga, R. The double life of the IGF-I receptor. Receptor, 2: 261-266, 1992.
9. Iwamura, M., Ishibe, M., Sluss, P. M., and Cockett, A. T. K. Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines. Urol. Res., 21: 27-32, 1993.
10. Christofori, G., Naik, P., and Hanahan, D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature (Lond.), 369: 414-418, 1994.
11. Giani, C., Cullen, K. J., Campani, K., and Rasmussen, A. IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ and immunohistochemistry study. Breast Cancer Res. Treat., 41: 43-50, 1996.
12. Rogler, C. E., Yang, D., Rossetti, L., Donohoe, J., Alt, E., Chang, C. J., Rosenfeld, R., Neely, K., and Hintz, R. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor II transgenic mice. J. Biol. Chem., 269; 13779-13784, 1994.
13. Tennant, R. W., Spalding, J., and French, J. E. Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutat. Res., 365; 119-127, 1996.
14. Underwood, L. E., Clemmons, D. R., Maes, M., D'Ercole, A. J., and Ketelslegers, J. M. Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Hormone Res., 24: 166-176, 1986.
15. 3H]thymidine administered by injection or osmotic pump. Carcinogenesis (Lond.), 11: 2245-2251, 1991.
16. Koss, L. G. Atlas of Tumor Pathology: Tumors of the Urinary Bladder, Vol. 11, p. 38. Washington, DC: Armed Forces Institute of Pathology, 1983.
17. James, S. J., and Muskhelishvili, L. Rates of apoptosis and proliferation vary with caloric intake and may influence incidence of spontaneous hepatoma in C57BL/ 6xC3H F1 mice. Cancer Res., 54: 5508-5510, 1994.
18. Grasl-Kraupp, B., Bursch, W., Ruttkay-Nedecky, B., Wagner, A., Lauer, B., and Schulte-Hermann, R. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc. Natl. Acad. Sci. USA, 91: 9995-9999, 1994.
19. Preston, G. A., Lang, J. E., Maronpot, R. R., and Barrett, J. C. Regulation of apoptosis by low serum in cells of different stages of neoplastic progression: enhanced susceptibility after loss of a senescence gene and decreased susceptibility after loss of a tumor suppressor gene. Cancer Res., 14: 4214-4223, 1994.
20. Chyle, V., Pollak, A., Czerniak, B., Stephens, L. C., Zagars, G. K., Terry, N. H., and Meyh, R. E. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int. J. Radiat. Oncol. Biol. Phys., 32: 281-287, 1996.
21. Resnicoff, M., Coppola, D., Sell, C., Rubin, R., Ferrone, S., and Baserga, R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res., 54: 4848-4850, 1994.
22. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
23. D'Ambrosio, C., Ferber, A., Resnicoff, M., and Baserga, R. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res., 56: 4013-4020, 1996.
24. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. C-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
25. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 2463-2469, 1995.
26. Neuenschwander, S., Schwartz, A., Wood, T. L., Roberts, C. T. J., Henninghausen, L., and LeRoith, D. Involution of the lactating mammary gland is inhibited by the IGF system in transgenic mouse model. J. Clin. Invest., 97: 2225-2232, 1996.
27. Nguyen, M., Wantanabe, H., Budson, A. E., Richte, J. P., and Folkman, J. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J. Natl. Cancer Inst., 83: 241-242, 1993.
28. Messing, E. M. Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors. Semin. Surg. Oncol., 8: 285-292, 1992.
29. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Differential angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
30. Rebel, J. M., Thijssen, C. D., Vermey, M., Zwarthoff, E. C., and VanderKwast, T. H. Modulation of intra-epithelial expansions of human T24 bladder cancer cells in murine urothelium by growth factors and extracellular matrix components. Int. J. Cancer. 60: 707-711, 1995.
31. Leventhal, P. S., and Feldman, E. L. Insulin-like growth factors as regulators of cell motility: signaling mechanisms. Trends Endocrinol. Metab., 8: 1-6, 1997.
32. Cooper, M. J., Fischer, M., Komitowski, D., Shevelev, A., Schulze, E., Ariel, I., Tykocinski, M. L., Miron, S., Ilan, J., de Groot, M., and Hochberg, A. Developmentally imprinted genes as markers for bladder tumor progression. J. Urol., 155: 2120-2127, 1996.
33. Kakizoe, T., Fair, W. R., Smith, P. H., Algaba, F., Ferrari, P., Grossman, H. B., Zirkali, Z., Tsukamoto, T., and Tachibana, M. What is the biology of invasion and metastasis of bladder cancer? Int. J. Urol., 2 (Suppl. 2): 58-63, 1995.
34. Daughaday, W. H. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology, 127: 1-4, 1990.
35. Friedl, A., Jordon, J. C., and Pollak, M. Suppression of serum insulin-like growth factor-I levels in breast cancer patients during adjuvant tamoxifen therapy. Eur. J. Cancer, 29A: 1368-1372, 1993.
36. Huynh, H., and Pollak, M. Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue. Biochem. Biophys. Res. Commun., 203; 253-259, 1994.
37. Pu, Y. S., Hsieh, T. S., Cheng, A. L., Tseng, N. F., Su, I. J., Hseih, C. Y., Lai, M. K., and Tsai, T. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy. Br. J. Urol., 77: 76-85, 1996.
38. Dunn, S. E., Hardman, R., Kari, F. W., and Barrett, J. C. Insulin-like growth factor I alters drug sensitivity of human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res., 57: 6795-6797, 1997.